13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q4 2016. See the latest, Q2 2026 →
Reported value
$308.47B
+2.0% on the quarter before
Positions
427
67 new · 53 sold out
Top 10
22.9%
of the value
Est. gain
+$5.34B
on stocks held all quarter
Est. return
+2.0%
on those stocks since Q3 2016
Positions as of Dec 31, 2016, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 40% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2016. Striped tiles are options.
Largest buys
Since Q3 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom Ltd~$5.61BNew · 0.0% → 1.8%+31,748,432 shares
- Accenture Plc Cl A~$3.33BNew · 0.0% → 1.1%+28,388,559 shares
- Medtronic Plc~$2.66BNew · 0.0% → 0.9%+37,304,796 shares
- Ubs Group Ag~$1.71BNew · 0.0% → 0.6%+109,253,117 shares
- Jpmorgan Chase & Co~$1.51BAdded · 0.3% → 0.9%+17,478,683 shares
- Nielsen Holdings Plc~$1.16BNew · 0.0% → 0.4%+27,723,831 shares
- Goldman Sachs~$1.15BAdded · 0.2% → 0.7%+4,804,607 shares
- Wells Fargo & Co~$1.01BAdded · 0.1% → 0.5%+18,266,087 shares
- Kroger Co~$938.6MAdded · 0.7% → 1.2%+27,196,485 shares
- Abbvie Inc~$857.2MAdded · 3.4% → 3.6%+13,688,625 shares
Largest sells
Since Q3 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom Ltd~$4.86BSold out · 1.6% → 0.0%−28,166,773 shares
- Accenture Plc Cl A~$3.47BSold out · 1.1% → 0.0%−28,388,103 shares
- Medtronic Plc~$3.28BSold out · 1.1% → 0.0%−37,968,014 shares
- Amgen Inc~$1.96BCut · 4.4% → 3.1%−13,429,520 shares
- Nielsen Holdings Plc~$1.45BSold out · 0.5% → 0.0%−26,974,590 shares
- Ubs Group Ag~$1.33BSold out · 0.4% → 0.0%−97,952,367 shares
- Alexion Pharmaceuticals Inc~$980.6MCut · 0.6% → 0.3%−8,014,731 shares
- Texas Instruments~$832.9MCut · 1.8% → 1.5%−11,413,677 shares
- Aetna Inc~$831.5MSold out · 0.3% → 0.0%−7,201,909 shares
- Flex Ltd~$788.8MSold out · 0.3% → 0.0%−57,911,422 shares
Holdings
As of Dec 31, 2016. Changes are in shares against Sep 30, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie IncCOMMON STOCK · shares +8.5% · price −0.7% | 3.6% | $10.96B | −$67.4M | ||||||||
| Amgen IncCOMMON STOCK · shares −17% · price −12.3% | 3.1% | $9.57B | −$1.35B | ||||||||
| AmazonCOMMON STOCK · shares +0.2% · price −10.4% | 2.6% | $8.04B | −$936.3M | ||||||||
| Verizon Communications IncCOMMON STOCK · shares −6.0% · price +2.7% | 2.4% | $7.54B | +$197.9M | ||||||||
| Philip Morris InternationalCOMMON STOCK · shares −10% · price −5.9% | 2.2% | $6.74B | −$421.9M | ||||||||
| NetflixCOMMON STOCK · shares +0.09% · price +25.6% | 2.1% | $6.41B | +$1.31B | ||||||||
| OracleCOMMON STOCK · shares −5.1% · price −2.1% | 1.9% | $5.87B | −$126.8M | ||||||||
| Broadcom LtdCOMMON STOCK · shares New | 1.8% | $5.61B | — | ||||||||
| American International Group IncCOMMON STOCK · shares +11% · price +10.1% | 1.6% | $5.09B | +$417.8M | ||||||||
| Texas InstrumentsCOMMON STOCK · shares −15% · price +4.0% | 1.5% | $4.68B | +$178.8M | ||||||||
| Altria Group IncCOMMON STOCK · shares −5.2% · price +6.9% | 1.5% | $4.61B | +$299.1M | ||||||||
| Union Pacific CorpCOMMON STOCK · shares −14% · price +6.3% | 1.4% | $4.43B | +$263.0M | ||||||||
| Canadian Natural Resources LtdCOMMON STOCK · shares −0.9% · price −0.3% | 1.3% | $4.16B | −$13.3M | ||||||||
| Stryker CorpCOMMON STOCK · shares +2.4% · price +2.9% | 1.3% | $4.11B | +$114.0M | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares −12% · price +14.3% | 1.3% | $4.08B | +$511.5M | ||||||||
| IntelCOMMON STOCK · shares +3.2% · price −3.9% | 1.3% | $4.03B | −$159.3M | ||||||||
| Eog Resources IncCOMMON STOCK · shares −9.3% · price +4.5% | 1.3% | $3.96B | +$171.9M | ||||||||
| Kroger CoCOMMON STOCK · shares +36% · price +16.3% | 1.2% | $3.57B | +$367.6M | ||||||||
| AlibabaCOMMON STOCK · shares +4.1% · price −17.0% | 1.1% | $3.54B | −$696.9M | ||||||||
| AlphabetCOMMON STOCK · shares +1.0% · price −0.7% | 1.1% | $3.45B | −$24.2M | ||||||||
| Accenture Plc Cl ACOMMON STOCK · shares New | 1.1% | $3.33B | — | ||||||||
| Halliburton CoCOMMON STOCK · shares +2.0% · price +20.5% | 1.1% | $3.32B | +$553.5M | ||||||||
| Boeing CoCOMMON STOCK · shares −5.6% · price +18.2% | 0.98% | $3.03B | +$465.3M | ||||||||
| Suncor Energy IncCOMMON STOCK · shares +11% · price +17.8% | 0.98% | $3.01B | +$410.6M | ||||||||
| AT&TCOMMON STOCK · shares −10% · price +4.7% | 0.96% | $2.96B | +$133.6M | ||||||||
| Total · 427 positions | 100% | $308.47B | +$5.34B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2016 to Q4 2016: 358 stocks held throughout, up $5.34B (+2.0%).
- Netflix+$1.31B+26%
- Halliburton Co+$553.5M+21%
- Unitedhealth Group Inc+$511.5M+14%
- Boeing Co+$465.3M+18%
- American International Group Inc+$417.8M+10%
- Philip Morris International−$421.9M−6%
- Alibaba−$696.9M−17%
- Illumina Inc−$716.4M−30%
- Amazon−$936.3M−10%
- Amgen Inc−$1.35B−12%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |